GB8812653D0 - Pharmaceutical composition based on high concentration esters of docosahexaenoic acid - Google Patents

Pharmaceutical composition based on high concentration esters of docosahexaenoic acid

Info

Publication number
GB8812653D0
GB8812653D0 GB888812653A GB8812653A GB8812653D0 GB 8812653 D0 GB8812653 D0 GB 8812653D0 GB 888812653 A GB888812653 A GB 888812653A GB 8812653 A GB8812653 A GB 8812653A GB 8812653 D0 GB8812653 D0 GB 8812653D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
high concentration
composition based
docosahexaenoic acid
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB888812653A
Other versions
GB2218904A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RENAFIELD Ltd
Original Assignee
RENAFIELD Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RENAFIELD Ltd filed Critical RENAFIELD Ltd
Priority to GB8812653A priority Critical patent/GB2218904A/en
Publication of GB8812653D0 publication Critical patent/GB8812653D0/en
Publication of GB2218904A publication Critical patent/GB2218904A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB8812653A 1988-05-27 1988-05-27 Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid Withdrawn GB2218904A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8812653A GB2218904A (en) 1988-05-27 1988-05-27 Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8812653A GB2218904A (en) 1988-05-27 1988-05-27 Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid

Publications (2)

Publication Number Publication Date
GB8812653D0 true GB8812653D0 (en) 1988-06-29
GB2218904A GB2218904A (en) 1989-11-29

Family

ID=10637693

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8812653A Withdrawn GB2218904A (en) 1988-05-27 1988-05-27 Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid

Country Status (1)

Country Link
GB (1) GB2218904A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436269A (en) * 1991-11-14 1995-07-25 Sagami Chemical Research Center Method for treating hepatitis
NL9201438A (en) * 1992-08-11 1994-03-01 Prospa Bv Novel pharmaceutical compositions comprising esters of omega-3 polyunsaturated acids and their use in the topical treatment of ailments.
FR2698269B1 (en) * 1992-11-24 1995-01-06 Inst Nat Sante Rech Med New drugs based on unsaturated fatty acids, usable in particular as antiplatelet agents and / or as preferred transporters to the brain.
IT1274734B (en) 1994-08-25 1997-07-24 Prospa Bv PHARMACEUTICAL COMPOSITIONS CONTAINING POLYUNSATURATED FATTY ACIDS, THEIR ESTERS OR SALTS, WITH VITAMINS OR ANTIOXIDANT PROVITAMINS
EP1886679A3 (en) * 1995-06-07 2008-05-28 Martek Biosciences Corporation Methods for controlling highly unsaturated fatty acid content in various tissues
US20030144219A1 (en) * 2001-11-15 2003-07-31 Phinney Stephen Dodge Formulations and methods for treatment or amelioration of inflammatory conditions
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
NZ539624A (en) * 2002-09-27 2008-08-29 Martek Biosciences Corp Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
CN1756545A (en) * 2003-03-05 2006-04-05 索尔瓦药物有限公司 Use of omega-3-fatty acids in the treatment of diabetic patients
EP1466597A1 (en) * 2003-04-07 2004-10-13 Clinigenetics Use of dha esters to control or prevent cardiovascular diseases
WO2004091603A1 (en) * 2003-04-07 2004-10-28 Clinigenetics Use of an ester of dha for the treatment of cardiovascular diseases
ITMI20040069A1 (en) 2004-01-21 2004-04-21 Tiberio Bruzzese USE OF HIGH CONCENTRATION N-3 FATTY ACID COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
GB0605900D0 (en) * 2006-03-23 2006-05-03 Lipigen As Modulators of nuclear receptors
US20100130608A1 (en) * 2008-10-01 2010-05-27 Martek Biosciences Corporation Compositions and methods for reducing triglyceride levels
CN109456395A (en) * 2018-12-21 2019-03-12 南京财经大学 A kind of incretin peptide and its application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
GB2098065A (en) * 1981-04-14 1982-11-17 Nippon Suisan Kaisha Ltd Antithrombotic compositions containing docosahexaenoic acid
JPS59172416A (en) * 1983-03-18 1984-09-29 Terumo Corp Fat transfusion solution
FR2548021B1 (en) * 1983-06-29 1986-02-28 Dick P R PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS

Also Published As

Publication number Publication date
GB2218904A (en) 1989-11-29

Similar Documents

Publication Publication Date Title
IL87079A0 (en) Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them
ZA854684B (en) Long-chain alpha-omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
HU891084D0 (en) Process for manufacturing of pharmaceutical compositions containing antiviricid and antibactericid fatty acids and monoglycerides
GB8812653D0 (en) Pharmaceutical composition based on high concentration esters of docosahexaenoic acid
EP0196625A3 (en) Resolution of racemic mixtures of aliphatic acid esters
IL78528A (en) Difluoro-naphthyridine-and trifluoro-quinoline-carboxylic acids and esters and salts thereof and pharmaceutical compositions containing them
IL92545A0 (en) Preparation of 2-chloropyridine-3-carboxylic acid esters
IL85969A0 (en) Ribofuranuronic acid derivatives and pharmaceutical compositions containing them
NZ216971A (en) Phosphonate esters and pharmaceutical compositions
IL78843A0 (en) Thiazolidine carboxylic acid derivatives and pharmaceutical and cosmetic compositions containing them
HUT40639A (en) Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them
NZ212388A (en) Deglucoteicoplanin carboxylic acid ester derivatives and pharmaceutical compositions
HUT50112A (en) Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component
PT82339A (en) Process for the preparation of novel androstane-17beta-carboxylic acid esters and of pharmaceutical compositions containing the same
PT82436A (en) Process for the preparation of 7-amino-3-propenylcephalosporanic acid and esters thereof
PT82836A (en) Process for the preparation of 3-(substituted)-propenylaminothiazolylcephalosporanic acids and esters thereof and of pharmaceutical compositions containing the same
IL88403A0 (en) Esters of pharmacologically active carboxylic acids,their manufacture and pharmaceutical compositions containing them
NZ224923A (en) 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions
IL84724A0 (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxyacetic acids and esters and amides thereof,their preparation and pharmaceutical compositions containing them
PT86776A (en) PROCESS FOR THE PREPARATION OF PIPERAZINECARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
HU895952D0 (en) Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them
EP0191735A3 (en) Novel oxaluric acid derivatives and pharmaceutical compositions containing them
NZ217724A (en) Esters of dihydrolysergic acid and pharmaceutical composition
NZ218614A (en) 16,17-butylidenedioxy-6,9-difluoro-11-hydroxy-3, 20-dioxopregna-1,4-diene-21-oic acid esters and pharmaceutical compositions
IL79947A (en) 4-alkoxy-3-pyrrolin-2-on-1-yl acetic acid esters and process for their preparation

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)